KRAS and colorectal carcinoma: found that treatment with bromelain in KRAS mutant murine models induced ferroptotic death in CRC cells by induction and upregulation of ACLS4. These results suggest ACSL4 inhibition as a therapeutic approach may prevent ferroptosis in relevant diseases.